All In MedTech

Device Trial Radar · NCT02286739

Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During Total Knee Arthroplasty (TKA)

Prospective Clinical Study Evaluating Tibiofemoral Rotational Alignment Using Intraoperative Sensing During Total Knee Arthroplasty

Last checked: Nov 20, 2026Latest source record: Aug 19, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

TerminatedResults posted on the registryPivotal-lookingRandomized with 500 participants. This is a heuristic, not a regulatory label.

Status

Terminated

Enrollment

500

Actual

Start

Apr 2015

Primary completion

May 2020

Study completion May 2020

Sponsor

Lead sponsor
Orthosensor, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Nov 10, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (participant)
Primary purpose
Basic science
Who can join
All sexes, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The objectives of the study are twofold: 1) Evaluate how intra-operative sensing may assist the surgeon with tibiofemoral rotational alignment by testing the precision and variability of setting tray rotation to the mid-third of the tibial tubercle. 2) Understand if patients with a combined axial rotation couple at the tibiofemoral joint and quantitative intercompartmental balance, achieved with the use of VERASENSE, exhibit less post-operative knee pain and improved clinical outcomes. Radiographic outcomes will also be assessed to measure post-operative alignment and to evaluate the prevalence and location of radiolucency and/or osteolysis.

Conditions

  • Osteoarthritis

Interventions

  • TKA with "Verasense"Device

    VERASENSE replaces the standard tibial trial inserts and is embedded with microelectronics and sensors to provide surgeons with real-time knee kinetic data. The data is wirelessly transmitted to a graphic display (VERASENSE Knee Application), allowing surgeons to quantify and assess soft tissue intercompartmental loads throughout the range of motion. The VERASENSE sensor is not an investigational device. OrthoSensor, Inc., received FDA pre-market submission (510K) clearance in 2009. The indication for use is a tool for adjustment of the femoral knee implant to reduce instability from flexion gap asymmetry. The VERASENSE sensor is sterile and single patient use.

  • TKA without "Verasense"Procedure

    TKA will be performed manually without the use of Verasense

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Quantitatively Balanced and Unbalanced Knees in Primary Unilateral Total Knee ArthroplastyTime frame: Intra-operative with trial implants in place and after completing all surgical corrections.

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • The Cleveland Clinic Foundation

    Weston, Florida

  • Emory University

    Atlanta, Georgia

  • Illinois Bone & Joint Institute

    Morton Grove, Illinois

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.